FDA.reportPublic FDA data

METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)

Substance profile for UNII 74G4R6TH13, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
74G4R6TH13
Preferred term
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)
Registry number
25086-15-1
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1309720
PubChem
0
NCIt
C80288
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1309720mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1309720
NCI ThesaurusC80288ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C80288
FDA Substance Registration System74G4R6TH13precision.fda.gov/uniisearch/srs/unii/74G4R6TH13

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
DRUG FACTS1
GLIPIZIDE ER1
DRUG FACTS4
735b22c9-ee92-49cd-a52e-f61dd6a45f691
These highlights do not include all the information needed to use Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules (MAS-ER) safely and effectively. See full prescribing information for MAS-ER Capsules. Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules (mixed salts of a single-entity amphetamine product), CII Initial U.S. Approv17
These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. OMEPRAZOLE Delayed-Release Capsules USP Initial U.S. Approval: 19895
90fd84ea-849c-48f2-956c-244166447e611
DRUG FACTS1
Drug Facts2
DRUG FACTS1
DRUG FACTS1
Drug Facts1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
Drug Facts3
These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral use Initial U.S. Approval: 200014
DRUG FACTS1
DRUG FACTS1
These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral use Initial U.S. Approval: 20001
DRUG FACTS1
Revised: January 2014 Glipizide Extended-Release Tablets For Oral Use Rx only2
DRUG FACTS1
Glipizide Extended-Release Tablets Revised: January 2013 Rx only1
Diclofenac Sodium Delayed-Release Tablets USP1
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP1
Drug Facts3
Nifedical XL ® (NIFEDIPINE) Tablet, Film Coated Extended Release USP1
Nifedical XL ® (NIFEDIPINE) Tablet, Film Coated Extended Release USP1
Drug Facts1
These highlights do not include all the information needed to use INTUNIV safely and effectively. See full prescribing information for INTUNIV . INTUNIV (guanfacine) extended-release tablets, for oral use Initial U.S. Approval: 1986 ® ® ®4
Naprelan5
These highlights do not include all the information needed to use Zolpidem Tartrate safely and effectively. See full prescribing information for Zolpidem Tartrate. Zolpidem Tartrate (Zolpidem Tartrate) TABLET, FILM COATED, EXTENDED RELEASE for ORAL use. Initial U.S. Approval: 19921
CEFUROXIME AXETIL FOR ORAL SUSPENSION,USP Rx Only1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
Drug Facts3
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
Diclofenac Sodium Delayed-Release Tablets USP4
Glipizide Extended-Release Tablets Revised: May 2012 Rx only 7002526610
DRUG FACTS1
bd2db700-0e4c-4e41-8ceb-05d3712063c72
DRUG FACTS1
DRUG FACTS1
Drug Facts2
DRUG FACTS2
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP6
Glipizide Extended-Release Tablets Rx only4
DRUG FACTS1
These highlights do not include all the information needed to use ADDERALL XR safely and effectively. See full prescribing information for ADDERALL XR. ADDERALL XR ® (mixed salts of a single-entity amphetamine product) dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, amphetamine sulfate capsules, CII Initial U.S. Approval: 20012
DRUG FACTS1
These highlights do not include all the information needed to use lansoprazole safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules, USP For oral administration Initial U.S. Approval: 19951
These highlights do not include all the information needed to use verapamil hydrochloride extended-release capsules (PM) safely and effectively. See full prescribing information for verapamil hydrochloride extended-release capsules (PM). Verapamil Hydrochloride Extended-release Capsules (PM) (Controlled Onset) for Oral use Initial U.S. Approval: 19982
Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use Omeprazole Delayed-Release Capsules safely and effectively. See full prescribing information for Omeprazole Delayed-Release Capsules. Initial U.S. Approval: 01/21/20091
These highlights do not include all the information needed to use Metoprolol Succinate Extended-Release Tablets USP safely and effectively. See full prescribing information for Metoprolol Succinate Extended-Release Tablets USP. Metoprolol Succinate Extended-Release Tablets USP Initial U.S. Approval: 19927
Sular ® (nisoldipine)1
Drug facts3
These highlights do not include all the information needed to use JALYN safely and effectively. See full prescribing information for JALYN. JALYN (dutasteride and tamsulosin hydrochloride) Capsules Initial U.S. Approval: 20101
Lansoprazole Delayed-Release Capsules USP, 15 mg2
These highlights do not include all the information needed to use Aggrenox Capsules safely and effectively. See full prescribing information for Aggrenox Capsules. AGGRENOX® (aspirin/extended-release dipyridamole) Capsules Initial U.S. Approval: 19992
162ffea4-4d08-4293-a03c-1256f8bb35331
e69fa3b1-f8eb-4289-bc79-f40f25cfa4181
These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 19872
These highlights do not include all the information needed to use DEXILANT safely and effectively. See full prescribing information for DEXILANT. DEXILANT (dexlansoprazole) delayed-release capsules, for oral use Initial U.S. Approval: 1995 (lansoprazole)2
ca5fa172-fd4a-4498-a88a-3265c54683841
Diclofenac Sodium Delayed-Release Tablets USP1
Glipizide Extended-Release Tablets Rx only1
These highlights do not include all the information needed to use tamsulosin hydrochloride safely and effectively. See full prescribing information for tamsulosin hydrochloride. Tamsulosin Hydrochloride Capsules USP*, 0.4 mg Initial U.S. Approval: 19971
a6b1858a-e796-4cb0-8a4d-d5c521874e841
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP2
These highlights do not include all the information needed to use Aggrenox Capsules safely and effectively. See full prescribing information for Aggrenox Capsules. AGGRENOX® (aspirin/extended-release dipyridamole) Capsules Initial U.S. Approval: 19991
Zolpidem Tartrate Extended-Release Tablets These highlights do not include all the information needed to use Zolpidem Tartrate safely and effectively. See full prescribing information for Zolpidem Tartrate. Zolpidem Tartrate (Zolpidem Tartrate) TABLET, FILM COATED, EXTENDED RELEASE for ORAL use. Initial U.S. Approval: 19921
f6c30ba1-53d0-4f85-a515-81acfb922e735
Metoprolol Succinate Extended-Release Tablets, USP 50 mg3
Metoprolol Succinate Extended-Release Tablets, USP 25 mg3
Metoprolol Succinate Extended-Release Tablets, USP 100 mg and 200 mg1
Nisoldipine2
DICLOFENAC SODIUM DELAYED RELEASE (DICLOFENAC SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3744
OMEPRAZOLE CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3741
KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3612
KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3413
BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3311
NIFEDICAL XL (NIFEDIPINE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1001
GLIPIZIDE ER (GLIPIZIDE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
NIFEDICAL XL (NIFEDIPINE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
TECFIDERA (DIMETHYL FUMARATE) KIT TECFIDERA (DIMETHYL FUMARATE) CAPSULE [BIOGEN INC.]32
INTUNIV (GUANFACINE) TABLET, EXTENDED RELEASE INTUNIV (GUANFACINE) KIT [SHIRE US MANUFACTURING INC.]27
LIALDA (MESALAMINE) TABLET, DELAYED RELEASE [SHIRE US MANUFACTURING INC.]26
PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]25
OMEPRAZOLE CAPSULE, DELAYED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.]23
ARTHROTEC (DICLOFENAC SODIUM AND MISOPROSTOL) TABLET, FILM COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]21
ADDERALL XR (DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE) CAPSULE, EXTENDED RELEASE [SHIRE US MANUFACTURING INC.]20
OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]19
MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]18
NAPROSYN (NAPROXEN) TABLET EC-NAPROSYN (NAPROXEN) TABLET, DELAYED RELEASE NAPROSYN (NAPROXEN) SUSPENSION ANAPROX (NAPROXEN SODIUM) TABLET ANAPROX DS (NAPROXEN SODIUM) TABLET [GENENTECH, INC.]18
DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]17
CIPRO (CIPROFLOXACIN HYDROCHLORIDE) TABLET, FILM COATED CIPRO (CIPROFLOXACIN) KIT [BAYER HEALTHCARE PHARMACEUTICALS INC.]15
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE CAPSULE, EXTENDED RELEASE [BARR LABORATORIES INC.]15
OMEPRAZOLE CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]15
APRISO (MESALAMINE) CAPSULE, EXTENDED RELEASE [SALIX PHARMACEUTICALS, INC.]14
DILTIAZEM HYDROCHLORIDE CAPSULE [REMEDYREPACK INC. ]14
JALYN (DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE) CAPSULE [GLAXOSMITHKLINE LLC]14
VERAPAMIL HYDROCHLORIDE PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]14
DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE) CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]13
DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE) CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]13
GLIPIZIDE ER (GLIPIZIDE) TABLET, FILM COATED, EXTENDED RELEASE [WATSON LABORATORIES, INC.]13
DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (DEXMETHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [SANDOZ INC]11
GLIPIZIDEER ER (GLIPIZIDE) TABLET, FILM COATED, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]11
ORAPRED ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING [SHIONOGI INC.]11

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 74G4R6TH13 page 1 of 1 · 8 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)74G4R6TH1325086151CAPSULEORAL40 mg
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)74G4R6TH1325086151CAPSULE, DELAYED RELEASEORAL79 mg
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)74G4R6TH1325086151CAPSULE, EXTENDED RELEASEORAL225 mg
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)74G4R6TH1325086151SUSPENSIONORALNA
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)74G4R6TH1325086151TABLETORAL13.65 mg
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)74G4R6TH1325086151TABLET, DELAYED RELEASEORAL172 mg
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)74G4R6TH1325086151TABLET, EXTENDED RELEASEORAL24 mg
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)74G4R6TH1325086151TABLET, ORALLY DISINTEGRATINGORAL98 mg